Deadline: 22-Aug-22
The NSW Health is inviting applications for the NSW COVID-19 Vaccine Acceleration Research Grants Program.
Objectives
The NSW COVID-19 Vaccine Acceleration Research Grants Program has been designed to:
- Specifically support research projects at Technology Readiness Levels 3B-6 (see Appendix A of the Guidelines below) that can rapidly undertake preclinical or early phase clinical studies to develop next-generation COVID-19 vaccines
-
Support research projects that address an unmet need in current COVID-19 vaccines, including (but not limited to) improving:
- vaccine safety profile
- resistance to new and/or multiple variants of SARS-CoV-2
- vaccine efficacy
- responses in immunocompromised or other at-risk populations
- the longevity of immunity
- Reduce the time from evidence generation to implementation, through rapid planning, conduct and reporting of research that will make good progress towards commercialisation and translation into clinical practice and policy
- Fund collaboration, leadership and capacity-building in the NSW vaccine research environment
- Bridge a funding gap which may halt the progress of next-generation COVID-19 vaccine research and development in NSW, and
- Support research that will add value to existing or planned initiatives, within the current Australian and international research landscape.
Funding Information
Funding of up to $1 million per project for a period of up to 24 months is available from the Office for Health and Medical Research.
Eligibility Criteria
Clinician researchers, researchers from culturally and linguistically diverse backgrounds, Aboriginal and Torres Strait Islander researchers and primary carers who have experienced career disruptions are encouraged to apply.
For more information, visit NSW Health.
For more information, visit https://www.medicalresearch.nsw.gov.au/covid-19-vaccine-acceleration-research-grants/